North America Drug Safety Solutions and Pharmacovigilance Market – Industry Trends and Forecast to 2026

  • Healthcare
  • Published Report
  • Oct 2019
  • North America
  • 350 Pages
  • No of Tables: 107
  • No of Figures: 36

North America Drug Safety Solutions and Pharmacovigilance Market By Type (Software, Services), End Users (Biotechnology & Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales), Country (U.S., Canada, Mexico)  – Industry Trends and Forecast to 2026

Drug safety and pharmacovigilance was introduced 170 years ago for detection, assessment, and understanding of the drug action. Pharmacovigilance came into picture because the adverse reactions were observed, a young woman from the north of England recorded for ADRs reactions which lead to her death in January 1848. The experiment was discovered by Sir James Simpson that chloroform was a powerful anesthetic and for safer use it can be applied in the clinical practices. The cause of Hannah’s death was studied in order to understand what happened to Hannah as it was difficult to assess the cause of her death and it was assumed that probably lethal arrhythmia or pulmonary aspiration was the main reason leading to such unfavourable situation. Further, on 6 June 1960, the U.S. FDA was formed to ensure that the established drugs discovered and commercialized are pure and free of any contamination. Additionally, in 1961, the U.S. FDA also prohibited false therapeutic indications of drugs.

Also, in 1961, European Pharmacovigilance was established after the tragedy of thalidomide which caused an adverse drug reaction named as phocomelia. In 1975, Practolol, a beta-receptor blocker agent, caused sclerosing peritonitis, and most recent is the event of 2007, where veralipride, a CNS depressant agent, caused so many ADRs such as anxiety, depression and movement disorders. Thus the medicines are made for life saving purpose, not for life threatening purpose. In the U.S., ADRs are among the top 10 causes of death, and in the U.K., it was observed that ADRs may cause 5,700 deaths per year.

North America drug safety solutions and pharmacovigilance market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.

Segmentation: North America Drug Safety Solutions and Pharmacovigilance Market

North America drug safety solutions and pharmacovigilance market is segmented into three notable segments which are type, end user and distribution channel.

  • On the basis of type, the market is segmented into software and services
  • On the basis of end user, the market is segmented into hospitals, healthcare providers, pharmaceutical & biotechnology industries, KPOs/BPOs, contract research organizations (CROS) and others 
  • On the basis of distribution channel, the market is segmented into direct sales and retail sales

 Competitive Analysis: North America Drug Safety Solutions and Pharmacovigilance Market​​​​​​​

Some of the major players operating in North America drug safety solutions and pharmacovigilance market are Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health among others. 

Recent Developments:

  • In September 2019, Pharmaceutical Product Development, LLC. acquired global site business. This acquisition was extended in Western Europe, North America, Latin America, Europe and South Africa with its therapeutic areas in the U.S. The acquisition helped in providing good values to CROs and sponsors and helped in attaining methodologies and values for the patients and the customers in drug and safety solutions market.

  • In September 2019, Pharmaceutical Research Associates Inc. launched Metys, a national market measurement tool. The product is only an integrated clinical solution for the life sciences companies. With this launch, the PRA Health Sciences, Inc. will be able to expand its market among all the present CROs.
  • In February 2019, ICON plc launched New Drug Safety Reporting Solution. The solution is an automated innovative cloud-based system which is designed to ensure compliance in an increasingly complex regulatory environment and allow safety profiling of an investigational product. The new solutions will help the company to increase its market share globally as the product will be used for regulatory intelligence in 80 countries.

Research Methodology: North America Drug Safety Solutions and Pharmacovigilance Market​​​​​​​

Primary Respondents:

Key Opinion Leaders (KOL’s): Doctors, Healthcare Professionals, Researchers, Distributors, and Industrialists

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers


SKU-

TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS

TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE

TABLE 3 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE,  2017-2026 (USD MILLION)

TABLE 4 NORTH AMERICA SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY REGION, 2017-2026 (USD MILLION)

TABLE 5 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE,  2017-2026 (USD MILLION)

TABLE 6 NORTH AMERICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 NORTH AMERICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 8 NORTH AMERICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 NORTH AMERICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 10 NORTH AMERICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 NORTH AMERICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 12 NORTH AMERICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 NORTH AMERICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 14 NORTH AMERICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 NORTH AMERICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 16 NORTH AMERICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 NORTH AMERICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 18 NORTH AMERICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION,  2017-2026 (USD MILLION)

TABLE 19 NORTH AMERICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE,  2017-2026 (USD MILLION)

TABLE 20 NORTH AMERICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 NORTH AMERICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 22 NORTH AMERICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY REGION, 2017-2026 (USD MILLION)

TABLE 23 NORTH AMERICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 24 NORTH AMERICA SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY REGION, 2017-2026 (USD MILLION)

TABLE 25 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY SERVICES, 2017-2026 (USD MILLION)

TABLE 26 NORTH AMERICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 27 NORTH AMERICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 28 NORTH AMERICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 29 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE,  BY END USER, 2017-2026 (USD MILLION)

TABLE 30 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 NORTH AMERICA HOSPITALS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY REGION, 2017-2026 (USD MILLION)

TABLE 33 NORTH AMERICA KPOS/BPOS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY REGION, 2017-2026 (USD MILLION)

TABLE 34 NORTH AMERICA HEALTHCARE PROVIDERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 NORTH AMERICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY REGION, 2017-2026 (USD MILLION)

TABLE 36 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 37 NORTH AMERICA DIRECT SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY REGION, 2017-2026 (USD MILLION)

TABLE 38 NORTH AMERICA RETAIL SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY REGION, 2017-2026 (USD MILLION)

TABLE 39 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 40 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY TYPE, 2017-2026 (USD MILLION)

TABLE 41 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 42 NORTH AMERICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 43 NORTH AMERICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 44 NORTH AMERICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 45 NORTH AMERICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 46 NORTH AMERICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 47 NORTH AMERICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 48 NORTH AMERICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 49 NORTH AMERICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 50 NORTH AMERICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 51 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY SERVICES, 2017-2026 (USD MILLION)

TABLE 52 NORTH AMERICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 53 NORTH AMERICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 54 NORTH AMERICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 55 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 56 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 57 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE,  2017-2026 (USD MILLION)

TABLE 58 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE,  2017-2026 (USD MILLION)

TABLE 59 U.S. ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 60 U.S. DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 61 U.S. DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 62 U.S. FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 63 U.S. ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 64 U.S. CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 65 U.S. REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 66 U.S. MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 67 U.S. OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 68 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES,  2017-2026 (USD MILLION)

TABLE 69 U.S. CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 70 U.S. DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 71 U.S. REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 72 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER,  2017-2026 (USD MILLION)

TABLE 73 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 74 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE,  2017-2026 (USD MILLION)

TABLE 75 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE,  2017-2026 (USD MILLION)

TABLE 76 CANADA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 77 CANADA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 78 CANADA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 79 CANADA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 80 CANADA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 81 CANADA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 82 CANADA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE,  2017-2026 (USD MILLION)

TABLE 83 CANADA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 84 CANADA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 85 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES,  2017-2026 (USD MILLION)

TABLE 86 CANADA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 87 CANADA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 88 CANADA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 89 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 90 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 91 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE,  2017-2026 (USD MILLION)

TABLE 92 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE,  2017-2026 (USD MILLION)

TABLE 93 MEXICO ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 94 MEXICO DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 95 MEXICO DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 96 MEXICO FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 97 MEXICO ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 98 MEXICO CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 99 MEXICO REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE,  2017-2026 (USD MILLION)

TABLE 100 MEXICO MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 101 MEXICO OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET,  BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 102 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES,  2017-2026 (USD MILLION)

TABLE 103 MEXICO CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 104 MEXICO DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 105 MEXICO REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 106 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER,  2017-2026 (USD MILLION)

TABLE 107 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19